HEALTHMEDPAGE TODAY
FDA Panel Narrowly Backs Lifting Restrictions on Peptides Backed by RFK Jr.
An FDA advisory committee voted to remove compounding restrictions on peptides BPC-157 and KPV, despite limited evidence of their safety or effectiveness for medical use. The decision was backed by RFK Jr., who promotes these peptides as wellness products.
Related Signal
Adjacent reporting
- FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures
- RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban
- FDA panel narrowly backs unapproved peptide drug touted by Joe Rogan and other influencers
- FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.
- FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.